SHPH (Shuttle Pharmaceuticals Holdings, Inc.) Stock Financials & Earnings | Market Cap Arena

SHPH (Shuttle Pharmaceuticals Holdings, Inc.) Stock Financials & Earnings | Market Cap Arena

SHPHShuttle Pharmaceuticals Holdings, Inc.

Mkt Cap$1M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$11M

EPS (TTM)-$5.64

Free Cash Flow (TTM)-$11M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Next: Q4 2025 · Mar 11

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$741K
Q1 23	$0	$0	-$2M
Q2 23	$0	$0	-$1M
Q3 23	$0	$0	-$2M
Q4 23	$0	-$2K	-$1M
Q1 24	$0	$0	-$1M
Q2 24	$0	$0	-$1M
Q3 24	$0	$0	-$3M
Q4 24	$0	-$2K	-$2M
Q1 25	$0	$0	-$3M
Q2 25	$0	$0	-$4M
Q3 25	$0	-$1K	-$2M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$680K	-$680K
Q1 23	-$1M	-$1M
Q2 23	-$2M	-$2M
Q3 23	-$2M	-$2M
Q4 23	-$1M	-$1M
Q1 24	-$1M	-$1M
Q2 24	-$1M	-$1M
Q3 24	-$2M	-$2M
Q4 24	-$3M	-$3M
Q1 25	-$3M	-$3M
Q2 25	-$3M	-$3M
Q3 25	-$3M	-$3M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$0
Q1 23	$0
Q2 23	$3
Q3 23	$19K
Q4 23	$4
Q1 24	$3
Q2 24	$2
Q3 24	$0
Q4 24	$2
Q1 25	$0
Q2 25	$0
Q3 25	$4

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	—	-25.1%
Q1 23	—	+142.0%
Q2 23	—	+314.5%
Q3 23	—	+94.7%
Q4 23	—	+73.2%
Q1 24	—	-10.4%
Q2 24	—	+1.2%
Q3 24	—	+90.8%
Q4 24	—	+38.5%
Q1 25	—	+113.1%
Q2 25	—	+163.7%
Q3 25	—	-25.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$47K	—
Q1 23	$8K	—
Q2 23	$0	—
Q3 23	$0	—
Q4 23	$87K	—
Q1 24	$111K	—
Q2 24	$71K	—
Q3 24	$45K	—
Q4 24	$32K	—
Q1 25	$537K	—
Q2 25	$47K	—
Q3 25	$134K	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 22	$112K	$641K	—
Q1 23	$922K	$623K	—
Q2 23	$840K	$626K	—
Q3 23	$1M	$554K	—
Q4 23	$433K	—	$848K
Q1 24	$586K	$799K	—
Q2 24	$646K	$837K	—
Q3 24	$1M	$2M	—
Q4 24	$986K	—	$789K
Q1 25	$2M	$1M	—
Q2 25	$1M	$3M	—
Q3 25	$943K	—	$1M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$8M	$0	$8M
Q1 23	$7M	$3M	$10M
Q2 23	$5M	$3M	$8M
Q3 23	$4M	$3M	$7M
Q4 23	$3M	$3M	$5M
Q1 24	$1M	$3M	$4M
Q2 24	$696K	$2M	$2M
Q3 24	$157K	$0	$157K
Q4 24	$2M	$0	$2M
Q1 25	$5M	$0	$5M
Q2 25	$5M	$0	$5M
Q3 25	$2M	$0	$2M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	14M	+33.8%
Q1 23	14M	+0.2%
Q2 23	14M	+4.6%
Q3 23	16M	+10.4%
Q4 23	16M	+2.1%
Q1 24	17M	+3.1%
Q2 24	10M	-37.7%
Q3 24	10M	+0.0%
Q4 24	4M	-60.5%
Q1 25	4M	+0.0%
Q2 25	1M	-72.4%
Q3 25	2M	+98.4%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 17	—	—
FY 18	—	—
FY 20	—	—
FY 21	—	—
FY 22	$0	7
FY 23	$0	8
FY 24	$0	9